PO.IM02.01 · 免疫学
乳腺癌的早期免疫格局及三级淋巴结构的作用
The early immune landscape of breast cancer and the role of tertiary lymphoid structures
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
导管原位癌(DCIS),即0期乳腺癌(BC),定义为肿瘤细胞局限于导管内。肿瘤浸润淋巴细胞(TIL)对乳腺浸润性导管癌(IDC)具有预后价值;然而,其在DCIS中的作用仍不明确。一些DCIS研究分析了TIL亚群的平衡,少数研究鉴定出三级淋巴结构(TLS),但由于结果相互矛盾,其在进展和复发中的作用仍不清楚。本研究旨在探讨浸润前BC病变中TIL的功能及其组织成TLS的情况。为前瞻性队列,在手术时从DCIS患者(n=19)、IDC患者(n=19)和乳腺缩小成形术(MR;n=8对照)中获取新鲜肿瘤样本。组织在不使用酶的情况下解离,并通过流式细胞术进行免疫表型分析。对一个FFPE组织蜡块的回顾性队列(DCIS n=30,IDC n=30)采用显色免疫组化(cIHC)进行CD3+CD20和PD-1+Ki67的双重染色,并对TILs和TLS评分,选定的患者(DCIS n=10,IDC n=10)还进行了多重IHC(mIHC)染色。我们通过重新分析公开的scRNA-seq数据集(DCIS n=6,IDC n=6)扩展分析,进一步探索免疫格局。患者按BC分子亚型进行匹配,以控制亚型之间的差异。在前瞻性队列中,DCIS相较于MR检测到更高比例的B细胞和滤泡辅助性T细胞(Tfh)TIL,前者与IDC水平相当,可能提示TLS的存在。在回顾性队列中,通过双重cIHC在75%的DCIS中检测到TLS,而IDC为58%,后者与我们此前对>300例IDC患者的分析一致。CD3、CD20、AID和CD23的空间mIHC分析显示,虽然AID+ B细胞在DCIS-TLS中较少,但CD23+成熟FDC的数量与IDC相当。因此,DCIS-TLS具有成熟的基质但Ig多样化有限,提示这些结构处于较早的分化阶段。Tfh细胞在B细胞成熟和抗体产生中发挥关键作用。前瞻性队列的流式细胞术数据检测到,DCIS中功能性CXCR5+PD1高ICOS中Tfh细胞的频率低于IDC。scRNA-seq分析显示,DCIS的Tfh更为幼稚,而IDC的Tfh具有增强的效应特征。在前瞻性队列中,以在IDC-TLS形成中发挥关键作用而闻名的产生CXCL13的CXCR5-PD1高ICOS中Tfh细胞在DCIS中也减少,且CXCL13表达主要在DCIS-TLS内的podoplanin+基质细胞中检测到。我们的数据表明,虽然在DCIS中观察到高密度的TIL和TLS,但适应性免疫应答不如IDC成熟,因此功能性也较弱。这可能部分解释了为何DCIS中密集的TIL和TLS不像IDC那样始终与良好预后相关。我们的发现凸显了需要超越简单量化,进一步剖析BC各阶段的免疫组成和空间组织。
查看英文原文 English abstract
Ductal carcinoma in situ (DCIS), stage 0 breast cancer (BC), is defined by tumor cells confined to the duct. Tumor infiltrating lymphocytes (TIL) are prognostic for invasive ductal carcinoma (IDC) of the breast; however, their role in DCIS remains unknown. Some DCIS studies have analyzed TIL subpopulation balances with a few identifying tertiary lymphoid structures (TLS) but their roles in progression and recurrence remains unclear due to contradictory findings. The aim of this study is to investigate the functionality and organization of TIL into TLS in pre-invasive BC lesions. Fresh tumor samples were obtained at surgery from patients with DCIS (n=19), IDC (n=19) and mammary reductions (MR; n=8 controls) for the prospective cohort. Tissues were dissociated without enzymes and immunophenotyped by flow cytometry. A retrospective cohort of FFPE tissue blocks (DCIS n=30, IDC n=30) were dual-stained by chromogenic immunohistochemistry (cIHC) for CD3+CD20 and PD-1+Ki67 and scored for TILs and TLS, with selected patients (DCIS n=10, IDC n=10) also stained by multiplex IHC (mIHC). We extended our analyses by re-analyzing public scRNA-seq datasets (DCIS n=6, IDC n=6) to further explore the immune landscape. Patients were matched by BC molecular subtypes to control variation between subtypes. In the prospective cohort, a higher proportion of B cell and T follicular helper (Tfh) TIL were detected in DCIS vs. MR, with the former paralleling IDC levels and potentially signaling a TLS presence. In the retrospective cohort, TLS were detected by dual cIHC in 75% of DCIS compared to 58% of IDC, the latter consistent with our previous analysis of >300 IDC patients. Spatial mIHC analysis of CD3, CD20, AID and CD23 revealed that while AID⁺ B cells were less frequent in DCIS-TLS the number of CD23⁺ mature FDC were comparable with IDC. Thus, DCIS-TLS have a mature stroma but limited Ig diversification, suggesting these structures are at an earlier stage of differentiation. Tfh cells play a crucial role in B cell maturation and antibody production. Flow cytometric data from the prospective cohort detected lower frequencies of functional CXCR5 + PD1 hi ICOS int Tfh cells in DCIS vs IDC. scRNA-seq analysis revealed that DCIS Tfh were more naïve, whereas IDC Tfh had enhanced effector signatures. In the prospective cohort, CXCL13-producing CXCR5⁻PD1 hi ICOS int Tfh cells, known for their critical role in IDC-TLS formation, were also reduced in DCIS with CXCL13 expression primarily detected in podoplanin⁺ stromal cells within DCIS-TLS. Our data show that while high densities of TIL and TLS are observed in DCIS, adaptive immunity responses are less mature and therefore less functional than in IDC. This may partly explain why dense TIL and TLS in DCIS are not consistently associated with a good prognosis, unlike IDC. Our findings highlight the need to further dissect, beyond simple quantification, the immune composition and spatial organization across BC stages.
利益披露 Disclosure
T. Vanhulst, None..
S. Garaud, None..
A. De Wind, None..
A. Boisson, None..
P. Delvaux, None..
D. Sofronii, None..
M. Langouo Fontsa, None..
K. Willard-Gallo, None.